Mary Mosher

Array ( [id] => 3646836 [patent_doc_number] => 05605691 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-25 [patent_title] => 'Immunologically active proteins from inclusion bodies' [patent_app_type] => 1 [patent_app_number] => 8/129027 [patent_app_country] => US [patent_app_date] => 1993-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 8988 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/605/05605691.pdf [firstpage_image] =>[orig_patent_app_number] => 129027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3513270 [patent_doc_number] => 05512452 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-30 [patent_title] => 'Selection of bacterial genes induced in host tissues' [patent_app_type] => 1 [patent_app_number] => 8/127905 [patent_app_country] => US [patent_app_date] => 1993-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 14214 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/512/05512452.pdf [firstpage_image] =>[orig_patent_app_number] => 127905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3523545 [patent_doc_number] => 05527700 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-18 [patent_title] => 'Target antigens of transmission blocking antibodies for malaria parasites' [patent_app_type] => 1 [patent_app_number] => 8/126593 [patent_app_country] => US [patent_app_date] => 1993-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9460 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/527/05527700.pdf [firstpage_image] =>[orig_patent_app_number] => 126593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3562438 [patent_doc_number] => 05482713 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-09 [patent_title] => 'Equine herpesvirus recombinant poxvirus vaccine' [patent_app_type] => 1 [patent_app_number] => 8/124668 [patent_app_country] => US [patent_app_date] => 1993-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 83 [patent_figures_cnt] => 84 [patent_no_of_words] => 34368 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/482/05482713.pdf [firstpage_image] =>[orig_patent_app_number] => 124668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3419018 [patent_doc_number] => 05478746 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-26 [patent_title] => 'cDNA encoding attenuated cell culture adapted hepatitis A virus genome' [patent_app_type] => 1 [patent_app_number] => 8/120646 [patent_app_country] => US [patent_app_date] => 1993-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3324 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/478/05478746.pdf [firstpage_image] =>[orig_patent_app_number] => 120646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3600831 [patent_doc_number] => 05578468 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-26 [patent_title] => 'Site-specific RNA cleavage' [patent_app_type] => 1 [patent_app_number] => 8/113646 [patent_app_country] => US [patent_app_date] => 1993-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 11941 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/578/05578468.pdf [firstpage_image] =>[orig_patent_app_number] => 113646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3687589 [patent_doc_number] => 05603933 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-18 [patent_title] => 'CD4 peptides for binding to viral envelope proteins' [patent_app_type] => 1 [patent_app_number] => 8/115171 [patent_app_country] => US [patent_app_date] => 1993-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15025 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/603/05603933.pdf [firstpage_image] =>[orig_patent_app_number] => 115171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4045526 [patent_doc_number] => 05869312 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'Recombinant swinepox virus' [patent_app_type] => 1 [patent_app_number] => 8/097554 [patent_app_country] => US [patent_app_date] => 1993-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 45 [patent_no_of_words] => 29470 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869312.pdf [firstpage_image] =>[orig_patent_app_number] => 097554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3489004 [patent_doc_number] => 05439814 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-08 [patent_title] => 'DNA encoding infectious rubella virus' [patent_app_type] => 1 [patent_app_number] => 8/093453 [patent_app_country] => US [patent_app_date] => 1993-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 4 [patent_no_of_words] => 6063 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/439/05439814.pdf [firstpage_image] =>[orig_patent_app_number] => 093453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3521591 [patent_doc_number] => 05503834 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-02 [patent_title] => 'Measles virus recombinant poxvirus vaccine' [patent_app_type] => 1 [patent_app_number] => 8/073962 [patent_app_country] => US [patent_app_date] => 1993-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 18567 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/503/05503834.pdf [firstpage_image] =>[orig_patent_app_number] => 073962 [rel_patent_id] =>[rel_patent_doc_number] =>)